/ R&D

Research
& Development.

XENKRYPT is committed to continuous innovation through its Research and Development division. We explore emerging technologies and develop cutting-edge solutions to stay ahead in the cybersecurity landscape.

[Placeholder for ADViSE Image]

ADViSE

Antitumor Drugs and Vaccines from the SEa

POR CAMPANIA FESR 2014/2020 - ASSE I. Public notice for the realization of a Technology Platform in the fight against oncological pathologies.

CUP: B43D18000240007

Total Project Amount: € 16.320.680,00

Financed Amount: € 12.094.158,00

Start Date: 22.11.2018

End Date: 31.12.2023

Duration: 36 months

About XENKRYPT

We are a next-generation cybersecurity firm built by young, certified professionals who live and breathe security. Unbound by legacy thinking, we bring fresh perspectives and relentless dedication to protect what matters most to your business.

12

Certified Professionals

24/7

Threat Monitoring

15+

Industry Certifications

100%

Commitment

Get in touch

Let's connect

Email Us

Get in touch via email

contact@xenkrypttechnologies.com

Call Us

Speak with our team

+91 9994488012

Visit Us

Our headquarters

SRMIST, Kattankulathur, India

XENKRYPT

XENKRYPT ©2026 All rights reserved